PPARG and Hepatic fibrosis: While these investigations established RNF41’s role in hepatic fibrosis through mechanisms involving macrophage phenotype switching via the C/EBP-β/PPAR-γ pathway and subsequent IGF-1-mediated HSC inactivation, they were limited to liver tissue analyses.